Abstract
Chondromodulating chimeric prodrugs of diacetylrhein were synthesized with an objective of potentiating its moderate anti-inflammatory effect and optimizing its hydrophilic/lipophilic balance by conjugating it with essential amino acids through a bioreversible amide linkage. In vitro release in HCl buffer (pH 1.2) showed insignificant release of diacetylrhein. However in phosphate buffer (pH 7.4), almost complete release of diacetylrhein was attained over a period of 4.5 h, following first order kinetics. The prodrug was screened extensively for therapeutic efficacy in monoiodoacetateinduced rat hyperalgesia model for levels of various markers of osteoarthritis, knee diameter and locomotor activity over a period of three months. Amongst the three prodrugs synthesized, diacetylrhein-L-tryptophan prodrug exhibited highest activity by reducing knee diameter, serum alkaline phosphatase and serum glucosaminoglycan to the baseline levels while increasing the spontaneous locomotor activity. It was found to provide maximum protection against Freund’s adjuvant arthritis with minimum ulcerogenic potential and better chondroprotection than diacetylrhein.
Keywords: Chimeric prodrugs, Diacetylrhein, Essential amino acids, IL-1 inhibitor, Monoiodoacetate-induced hyperalgesia, Osteoarthritis, Ulcerogenicity, hyaluronic acid, D-phenylalanine, L-tryptophan
Medicinal Chemistry
Title:Chondromodulating Chimeric Prodrugs of Diacetylrhein: Synthesis and Evaluation in Monoiodoacetate-induced Hyperalgesia
Volume: 9 Issue: 3
Author(s): Suneela Dhaneshwar and Dipmala Patil
Affiliation:
Keywords: Chimeric prodrugs, Diacetylrhein, Essential amino acids, IL-1 inhibitor, Monoiodoacetate-induced hyperalgesia, Osteoarthritis, Ulcerogenicity, hyaluronic acid, D-phenylalanine, L-tryptophan
Abstract: Chondromodulating chimeric prodrugs of diacetylrhein were synthesized with an objective of potentiating its moderate anti-inflammatory effect and optimizing its hydrophilic/lipophilic balance by conjugating it with essential amino acids through a bioreversible amide linkage. In vitro release in HCl buffer (pH 1.2) showed insignificant release of diacetylrhein. However in phosphate buffer (pH 7.4), almost complete release of diacetylrhein was attained over a period of 4.5 h, following first order kinetics. The prodrug was screened extensively for therapeutic efficacy in monoiodoacetateinduced rat hyperalgesia model for levels of various markers of osteoarthritis, knee diameter and locomotor activity over a period of three months. Amongst the three prodrugs synthesized, diacetylrhein-L-tryptophan prodrug exhibited highest activity by reducing knee diameter, serum alkaline phosphatase and serum glucosaminoglycan to the baseline levels while increasing the spontaneous locomotor activity. It was found to provide maximum protection against Freund’s adjuvant arthritis with minimum ulcerogenic potential and better chondroprotection than diacetylrhein.
Export Options
About this article
Cite this article as:
Dhaneshwar Suneela and Patil Dipmala, Chondromodulating Chimeric Prodrugs of Diacetylrhein: Synthesis and Evaluation in Monoiodoacetate-induced Hyperalgesia, Medicinal Chemistry 2013; 9 (3) . https://dx.doi.org/10.2174/1573406411309030015
DOI https://dx.doi.org/10.2174/1573406411309030015 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
High Throughput Study for Molecular Mechanism of Metformin
Pre-Diabetic Protection <i>via</i> Microarray Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Development and a Practical Synthesis of Nepafenac Intermediate via Modified Gassman Reaction
Letters in Organic Chemistry The Role of the Immune System in the Pathogenesis of Hypertension
Current Hypertension Reviews Various Carbonic Anhydrases in Physiopathological Events, Carbonic Anhydrase Inhibitors, and Hybrid Compounds
Letters in Drug Design & Discovery Therapeutic Targets for Heart Failure: Beyond Beta-Adrenergic and Renin-Angiotensin System Blockade
Recent Patents on Cardiovascular Drug Discovery Rubiscolins - Highly Potent Peptides Derived from Plant Proteins
Mini-Reviews in Medicinal Chemistry Myogenic Potential of Mesenchymal Stem Cells - the Case of Adhesive Fraction of Human Umbilical Cord Blood Cells
Current Stem Cell Research & Therapy 5q- syndrome
Current Pharmaceutical Design Intravenous Application of Allogenic Peripheral Blood-Derived Mesenchymal Stem Cells: A Safety Assessment in 291 Equine Recipients
Current Stem Cell Research & Therapy Omega – 3 Fatty Acids as Pharmacotherapeutics in Psoriasis: Current Status and Scope of Nanomedicine in its Effective Delivery
Current Drug Targets NO to Breast: When, Why and Why Not?
Current Pharmaceutical Design Mechanisms of Esophageal Protection, Gastroprotection and Ulcer Healing by Melatonin. Implications for the Therapeutic use of Melatonin in Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease
Current Pharmaceutical Design Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery
Current Pharmaceutical Design The Use of Structural Biology in Janus Kinase Targeted Drug Discovery
Current Drug Targets FoxO3a Governs Early Microglial Proliferation and Employs Mitochondrial Depolarization with Caspase 3, 8, and 9 Cleavage During Oxidant Induced Apoptosis
Current Neurovascular Research Can Topiramate Induce Pruritus? A Case Report and Review of Literature
CNS & Neurological Disorders - Drug Targets Nutraceuticals: Beyond the Diet Before the Drugs
Current Bioactive Compounds Structural Variability in the RLR-MAVS Pathway and Sensitive Detection of Viral RNAs
Medicinal Chemistry Valproic Acid and Propionic Acid Modulated Mechanical Pathways Associated with Autism Spectrum Disorder at Prenatal and Neonatal Exposure
CNS & Neurological Disorders - Drug Targets Vulnerable Plaque and Inflammation: Potential Clinical Strategies
Current Pharmaceutical Design